AI Portfolio Summary
In 2025 Q4, Exome Asset Management LLC maintained a portfolio of 94 distinct positions. The most significant new addition to the portfolio was WAVE LIFE SCIENCES L, which now represents 3.43% of the total fund value. Conversely, Exome Asset Management LLC completely exited their position in 89BIO INC.
Total Positions
94
Quarter
2025 Q4
Top Holding
PRAX (8.2%)
Top 10 Concentration
42.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 94
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 8.19% | 3.27% |
#1
7
Prev: #8
|
3.4 | -43,874 | -43.0% |
P
S
|
58,122 | $17,130,878 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 5.19% | 3.86% |
#2
2
Prev: #4
|
2.2 | -137,979 | -31.1% |
P
S
|
305,568 | $10,853,775 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 4.79% | 3.71% |
#3
2
Prev: #5
|
1.9 | no change | no change |
P
S
|
98,182 | $10,028,309 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 4.41% | 5.19% |
#4
3
Prev: #1
|
1.8 | -14,501 | -11.1% |
P
S
|
116,515 | $9,217,502 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 4.03% | 3.63% |
#5
1
Prev: #6
|
1.6 | no change | no change |
P
S
|
7,852 | $8,438,387 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 3.79% | 4.74% |
#6
4
Prev: #2
|
1.6 | -17,668 | -12.4% |
P
S
|
124,749 | $7,926,551 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 3.43% | — |
#7
Prev: #—
|
3.4 | 421,488 | no change |
NEW
|
421,488 | $7,165,296 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 3.01% | 2.75% |
#8
1
Prev: #9
|
1.3 | -31,681 | -20.3% |
P
S
|
124,391 | $6,299,160 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 2.95% | 4.19% |
#9
6
Prev: #3
|
1.3 | -52,364 | -39.3% |
P
S
|
80,723 | $6,174,502 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELV
ELEVANCE HEALTH...
|
Healthcare | 2.88% | — |
#10
Prev: #—
|
3.2 | 17,191 | no change |
NEW
|
17,191 | $6,026,305 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AZN
ASTRAZENECA PLC
|
Healthcare | 2.52% | 2.59% |
#11
1
Prev: #10
|
1.0 | no change | no change |
P
S
|
28,362 | $5,260,652 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 2.15% | — |
#12
Prev: #—
|
2.9 | 26,494 | no change |
NEW
|
26,494 | $4,503,980 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NTRA
NATERA INC
|
Healthcare | 2.04% | 1.82% |
#13
6
Prev: #19
|
0.8 | no change | no change |
P
S
|
18,650 | $4,272,529 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 1.93% | 1.55% |
#14
13
Prev: #27
|
0.8 | no change | no change |
P
S
|
158,622 | $4,032,171 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UHS
UNIVERSAL HLTH ...
|
Healthcare | 1.84% | 0.98% |
#15
26
Prev: #41
|
3.0 | 9,673 | 121.6% |
P
S
|
17,628 | $3,843,257 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 1.79% | 1.69% |
#16
7
Prev: #23
|
2.8 | 1,040 | 15.7% |
P
S
|
7,685 | $3,744,516 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 1.78% | — |
#17
Prev: #—
|
2.7 | 136,942 | no change |
NEW
|
136,942 | $3,727,561 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 1.77% | 2.46% |
#18
7
Prev: #11
|
0.8 | -14,613 | -23.8% |
P
S
|
46,743 | $3,711,862 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 1.72% | 1.72% |
#19
2
Prev: #21
|
0.7 | no change | no change |
P
S
|
6,358 | $3,600,917 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 1.70% | 1.34% |
#20
11
Prev: #31
|
2.7 | 4,328 | 15.9% |
P
S
|
31,471 | $3,553,391 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 1.64% | — |
#21
Prev: #—
|
2.7 | 222,308 | no change |
NEW
|
222,308 | $3,423,543 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CELC
CELCUITY INC
|
Healthcare | 1.64% | — |
#22
Prev: #—
|
2.7 | 34,289 | no change |
NEW
|
34,289 | $3,419,985 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APLS
APELLIS PHARMAC...
|
Healthcare | 1.63% | — |
#23
Prev: #—
|
2.7 | 135,849 | no change |
NEW
|
135,849 | $3,412,527 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 1.63% | 2.27% |
#24
10
Prev: #14
|
0.8 | -67,865 | -43.2% |
P
S
|
89,052 | $3,402,677 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DXCM
DEXCOM INC
|
Healthcare | 1.59% | — |
#25
Prev: #—
|
2.6 | 50,147 | no change |
NEW
|
50,147 | $3,328,256 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ETNB
89BIO INC
|
Unknown | 0.00% | 2.44% |
Sold All 😨
(Was: #12) |
0.3 | -273,661 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 0.00% | 2.27% |
Sold All 😨
(Was: #13) |
0.3 | -94,400 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CVS
CVS HEALTH CORP
|
Healthcare | 0.00% | 1.99% |
Sold All 😨
(Was: #17) |
0.3 | -43,600 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 0.00% | 1.98% |
Sold All 😨
(Was: #18) |
0.3 | -48,445 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 1.68% |
Sold All 😨
(Was: #24) |
0.3 | -58,579 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PPH
CALL
VANECK ETF TRUS...
|
CALL Option | 0.00% | 1.64% |
Sold All 😨
(Was: #25) |
0.3 | -30,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CALL
TRAVERE THERAPE...
|
—
|
CALL Option | 0.00% | 1.59% |
Sold All 😨
(Was: #26) |
0.3 | -110,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
GERN
GERON CORP
|
Healthcare | 0.00% | 1.54% |
Sold All 😨
(Was: #28) |
0.3 | -1,858,354 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 0.00% | 1.29% |
Sold All 😨
(Was: #33) |
0.3 | -88,024 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CALL
NOVO-NORDISK A ...
|
—
|
CALL Option | 0.00% | 1.18% |
Sold All 😨
(Was: #34) |
0.3 | -35,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
COR
CENCORA INC
|
Healthcare | 0.00% | 1.14% |
Sold All 😨
(Was: #36) |
0.3 | -6,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 0.00% | 1.10% |
Sold All 😨
(Was: #37) |
0.3 | -117,783 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
SAREPTA THERAPE...
|
—
|
Bond/Debt | 0.00% | 1.07% |
Sold All 😨
(Was: #39) |
0.3 | -2,000,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
KARYOPHARM THER...
|
—
|
Bond/Debt | 0.00% | 0.99% |
Sold All 😨
(Was: #40) |
0.3 | -2,000,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.00% | 0.88% |
Sold All 😨
(Was: #42) |
0.3 | -120,644 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRCT
PROCEPT BIOROBO...
|
Healthcare | 0.00% | 0.86% |
Sold All 😨
(Was: #43) |
0.3 | -39,900 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSP
INSPIRE MED SYS...
|
Healthcare | 0.00% | 0.84% |
Sold All 😨
(Was: #44) |
0.3 | -18,600 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QURE
UNIQURE NV
|
Healthcare | 0.00% | 0.78% |
Sold All 😨
(Was: #45) |
0.3 | -22,090 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 0.00% | 0.77% |
Sold All 😨
(Was: #46) |
0.3 | -178,084 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.00% | 0.77% |
Sold All 😨
(Was: #47) |
0.3 | -100,036 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
PUT
LIQUIDIA CORPOR...
|
—
|
PUT Option | 0.00% | 0.73% |
Sold All 😨
(Was: #48) |
0.3 | -53,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
PUT
ARCTURUS THERAP...
|
—
|
PUT Option | 0.00% | 0.56% |
Sold All 😨
(Was: #52) |
0.3 | -50,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 0.00% | 0.56% |
Sold All 😨
(Was: #53) |
0.3 | -52,402 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
PUT
MBX BIOSCIENCES...
|
—
|
PUT Option | 0.00% | 0.54% |
Sold All 😨
(Was: #55) |
0.3 | -50,500 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
CALL
COGENT BIOSCIEN...
|
—
|
CALL Option | 0.00% | 0.39% |
Sold All 😨
(Was: #56) |
0.3 | -45,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
PUT
CENTESSA PHARMA...
|
—
|
PUT Option | 0.00% | 0.37% |
Sold All 😨
(Was: #57) |
0.3 | -25,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
CALL
PRAXIS PRECISIO...
|
—
|
CALL Option | 0.00% | 0.32% |
Sold All 😨
(Was: #59) |
0.3 | -10,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
CALL
MBX BIOSCIENCES...
|
—
|
CALL Option | 0.00% | 0.32% |
Sold All 😨
(Was: #60) |
0.3 | -30,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
ACAD
PUT
ACADIA PHARMACE...
|
PUT Option | 0.00% | 0.26% |
Sold All 😨
(Was: #61) |
0.3 | -20,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
PUT
KARYOPHARM THER...
|
—
|
PUT Option | 0.00% | 0.19% |
Sold All 😨
(Was: #64) |
0.3 | -48,100 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 0.00% | 0.19% |
Sold All 😨
(Was: #65) |
0.3 | -73,614 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VTYX
VENTYX BIOSCIEN...
|
Healthcare | 0.00% | 0.11% |
Sold All 😨
(Was: #66) |
0.3 | -60,600 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMUX
IMMUNIC INC
|
Healthcare | 0.00% | 0.09% |
Sold All 😨
(Was: #67) |
0.3 | -173,900 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATYR
CALL
ATYR PHARMA INC
|
CALL Option | 0.00% | 0.02% |
Sold All 😨
(Was: #68) |
0.3 | -40,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 94 holdings